bd 1047 has been researched along with sm 346 in 4 studies
Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (sm 346) | Trials (sm 346) | Recent Studies (post-2010) (sm 346) |
---|---|---|---|---|---|
118 | 0 | 54 | 129 | 8 | 57 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Behensky, A; Cuevas, J; Katnik, C; Rodriguez, A | 1 |
Behensky, A; Cuevas, J; Deng, W; Katnik, C | 1 |
Kadnikov, IA; Seredenin, SB; Voronin, MV; Voronkov, DN | 1 |
Kadnikov, IA; Seredenin, SB; Verbovaya, ER; Voronin, MV; Voronkov, DN | 1 |
4 other study(ies) available for bd 1047 and sm 346
Article | Year |
---|---|
Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors.
Topics: Adenosine Triphosphate; Animals; Anti-Anxiety Agents; Benzimidazoles; Brain Ischemia; Butyrates; Calcium; Cell Death; Cell Survival; Ethylenediamines; Female; Membrane Potentials; Microglia; Morpholines; Patch-Clamp Techniques; Piperazines; Pregnancy; Purinergic P2X Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor; Tropanes; Uridine Triphosphate | 2011 |
Afobazole modulates neuronal response to ischemia and acidosis via activation of sigma-1 receptors.
Topics: Acidosis; Animals; Anti-Anxiety Agents; Benzimidazoles; Brain Ischemia; Calcium; Cell Survival; Cerebral Cortex; Ethylenediamines; Female; Guanidines; Indicators and Reagents; L-Lactate Dehydrogenase; Membrane Potentials; Morpholines; Narcotics; Neurons; Patch-Clamp Techniques; Pentazocine; Phencyclidine; Piperazines; Pregnancy; Rats; Receptors, sigma; Sigma-1 Receptor | 2011 |
Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.
Topics: Animals; Benzimidazoles; Corpus Striatum; Disease Models, Animal; Dopamine; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Morpholines; Neurons; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptors, sigma; Rotarod Performance Test; Sigma-1 Receptor; Substantia Nigra | 2019 |
Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson's Disease.
Topics: Animals; Benzimidazoles; Corpus Striatum; Dopamine; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Morpholines; Movement; Parkinson Disease; Receptors, sigma; Sigma-1 Receptor | 2020 |